11-108227849-C-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP2_StrongBA1

This summary comes from the ClinGen Evidence Repository: The ATM c.146C>G (p.Ser49Cys) variant has a GnomAD (v2.1.1) filtering allele frequency of 1.208% (NFE) which is above the ATM BA1 threshold of .5% (BA1). This variant has been observed in a homozygous and/or compound heterozygous state (presumed) in multiple individuals without Ataxia-Telangiectasia (Laboratory data) (BP2_Strong). In summary, this variant meets criteria to be classified as benign based on the ACMG/AMP criteria applied as specified by the HBOP Variant Curation Expert Panel. LINK:https://erepo.genome.network/evrepo/ui/classification/CA202190/MONDO:0016419/020

Frequency

Genomes: 𝑓 0.0072 ( 6 hom., cov: 33)
Exomes 𝑓: 0.011 ( 126 hom. )

Consequence

ATM
NM_000051.4 missense

Scores

6
11

Clinical Significance

Benign reviewed by expert panel U:1B:34O:1

Conservation

PhyloP100: 2.00

Publications

101 publications found
Variant links:
Genes affected
ATM (HGNC:795): (ATM serine/threonine kinase) The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010]
ATM Gene-Disease associations (from GenCC):
  • ATM-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • hereditary breast carcinoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • ataxia telangiectasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, Laboratory for Molecular Medicine
  • prostate cancer
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • sarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • gastric carcinoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • hereditary nonpolyposis colon cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP2
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000051.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATM
NM_000051.4
MANE Select
c.146C>Gp.Ser49Cys
missense
Exon 3 of 63NP_000042.3
ATM
NM_001351834.2
c.146C>Gp.Ser49Cys
missense
Exon 4 of 64NP_001338763.1Q13315
ATM
NM_001351835.2
c.146C>Gp.Ser49Cys
missense
Exon 3 of 4NP_001338764.1Q6P7P1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATM
ENST00000675843.1
MANE Select
c.146C>Gp.Ser49Cys
missense
Exon 3 of 63ENSP00000501606.1Q13315
ATM
ENST00000452508.7
TSL:1
c.146C>Gp.Ser49Cys
missense
Exon 4 of 64ENSP00000388058.2Q13315
ATM
ENST00000531525.3
TSL:1
c.146C>Gp.Ser49Cys
missense
Exon 3 of 30ENSP00000434327.3H0YDU7

Frequencies

GnomAD3 genomes
AF:
0.00727
AC:
1105
AN:
152090
Hom.:
6
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00270
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00380
Gnomad ASJ
AF:
0.000577
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00352
Gnomad FIN
AF:
0.00180
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0131
Gnomad OTH
AF:
0.00382
GnomAD2 exomes
AF:
0.00712
AC:
1789
AN:
251092
AF XY:
0.00716
show subpopulations
Gnomad AFR exome
AF:
0.00210
Gnomad AMR exome
AF:
0.00304
Gnomad ASJ exome
AF:
0.000595
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00259
Gnomad NFE exome
AF:
0.0126
Gnomad OTH exome
AF:
0.00686
GnomAD4 exome
AF:
0.0114
AC:
16678
AN:
1461052
Hom.:
126
Cov.:
32
AF XY:
0.0111
AC XY:
8053
AN XY:
726760
show subpopulations
African (AFR)
AF:
0.00194
AC:
65
AN:
33456
American (AMR)
AF:
0.00293
AC:
131
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.000651
AC:
17
AN:
26118
East Asian (EAS)
AF:
0.0000253
AC:
1
AN:
39594
South Asian (SAS)
AF:
0.00399
AC:
343
AN:
86040
European-Finnish (FIN)
AF:
0.00272
AC:
145
AN:
53398
Middle Eastern (MID)
AF:
0.00406
AC:
23
AN:
5668
European-Non Finnish (NFE)
AF:
0.0138
AC:
15387
AN:
1111718
Other (OTH)
AF:
0.00938
AC:
566
AN:
60340
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
786
1572
2359
3145
3931
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
614
1228
1842
2456
3070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00724
AC:
1102
AN:
152206
Hom.:
6
Cov.:
33
AF XY:
0.00640
AC XY:
476
AN XY:
74416
show subpopulations
African (AFR)
AF:
0.00270
AC:
112
AN:
41554
American (AMR)
AF:
0.00379
AC:
58
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.000577
AC:
2
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00311
AC:
15
AN:
4822
European-Finnish (FIN)
AF:
0.00180
AC:
19
AN:
10576
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0131
AC:
888
AN:
67986
Other (OTH)
AF:
0.00378
AC:
8
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
56
112
168
224
280
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00847
Hom.:
1
Bravo
AF:
0.00734
TwinsUK
AF:
0.0129
AC:
48
ALSPAC
AF:
0.0114
AC:
44
ESP6500AA
AF:
0.00273
AC:
12
ESP6500EA
AF:
0.0136
AC:
117
ExAC
AF:
0.00736
AC:
894
Asia WGS
AF:
0.00115
AC:
4
AN:
3476
EpiCase
AF:
0.0109
EpiControl
AF:
0.0125

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
10
not specified (10)
-
-
7
Hereditary cancer-predisposing syndrome (7)
-
-
6
Ataxia-telangiectasia syndrome (6)
-
-
6
not provided (6)
-
-
2
Familial cancer of breast (2)
-
-
1
ATM-related cancer predisposition (1)
-
-
1
Hereditary breast ovarian cancer syndrome (1)
-
-
1
Malignant tumor of breast (1)
-
1
-
Tip-toe gait (1)
-
-
-
Breast cancer, susceptibility to (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.078
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.36
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.071
T
Eigen
Uncertain
0.19
Eigen_PC
Benign
0.14
FATHMM_MKL
Benign
0.50
D
LIST_S2
Benign
0.81
T
MetaRNN
Benign
0.0056
T
MetaSVM
Benign
-0.97
T
MutationAssessor
Uncertain
2.3
M
PhyloP100
2.0
PrimateAI
Benign
0.41
T
PROVEAN
Uncertain
-2.6
D
REVEL
Benign
0.060
Sift
Uncertain
0.0030
D
Sift4G
Uncertain
0.0060
D
Polyphen
0.98
D
Vest4
0.42
MVP
0.85
MPC
0.48
ClinPred
0.032
T
GERP RS
4.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.11
gMVP
0.23
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1800054; hg19: chr11-108098576; COSMIC: COSV53745984; COSMIC: COSV53745984; API